AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ImageneBio, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00XZY4TH8
4.22▲ 0.17 (4.33%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
4.05
Day's Range
3.98 – 4.30
52-Week Range
3.90 – 9.10
Volume
7,869
Avg Volume
14.8K
Share Statistics
Shares Outstanding
Employees
15
Exchange
XNAS
Listed
2025-07-28
Share count as of July 31, 2026

ImageneBio, Inc. Common Stock (IMA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about ImageneBio, Inc. Common Stock (IMA)
What is ImageneBio, Inc. Common Stock's Market Cap?
ImageneBio, Inc. Common Stock's Market Cap is $47.9M, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's Enterprise Value?
ImageneBio, Inc. Common Stock's Enterprise Value is -$88.2M, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's Price / Sales?
ImageneBio, Inc. Common Stock's Price / Sales is 59.9×, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's EV / Revenue?
ImageneBio, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's EV / EBITDA?
ImageneBio, Inc. Common Stock's EV / EBITDA is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's Revenue (TTM)?
ImageneBio, Inc. Common Stock's Revenue (TTM) is $800.0K, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's Net Income (TTM)?
ImageneBio, Inc. Common Stock's Net Income (TTM) is -$52.5M, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's EBITDA?
ImageneBio, Inc. Common Stock's EBITDA is -$58.6M, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's Diluted EPS (TTM)?
ImageneBio, Inc. Common Stock's Diluted EPS (TTM) is -4.62, based on as-reported figures from SEC (XBRL) filings.
What is ImageneBio, Inc. Common Stock's EBITDA Margin?
ImageneBio, Inc. Common Stock's EBITDA Margin is -7320.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IMAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
License revenue——
YoY growth———-100.0%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue————
Loss from operations
% of revenue————
Other income (expense):
Interest income (expense)
Other income , net
Total other income (expense), net
Loss before income taxes
Income tax expense
Net loss
% of revenue————
Net loss attributable to common stockholders
Net loss per share, basic
Net loss per share, diluted